Family Promoting Positive Emotions Pilot Study

Depression Clinical Trial

Official title: Targeting Positive Emotions to Prevent Emotional Disturbances in Children During COVID-19

Status Completed

Clinical Trial Summary

Anhedonia is characterized by loss of interest or pleasure. The proposed pilot study would be the first to test an innovative, neuroscience-informed intervention in mothers reporting depressive symptoms and stress to enhance positive emotionality with the goal of preventing anhedonia and associated emotional disturbances in their children. This study will recruit dyads (mothers and their children) for the intervention.

Clinical Trial Description

Anhedonia, characterized by loss of interest or pleasure, is a primary symptom of depression. Depression is increasingly prevalent and can cause significant impairments in life functioning. Given the increased presence of stress during COVID-19, there is a significant need for interventions that can prevent the development of anhedonia and depression. This study examines a neuroscience-informed positive emotion intervention to determine its effects on preventing anhedonia and associated emotional disturbances in dyads of children and their mothers. Participants will be randomized to either receive the positive emotion intervention for 8 sessions for 8 weeks with a clinician or the self-administered written information condition. Depressive symptoms, anhedonia, stress and other internalizing disorders will be assessed at baseline, and at the end of the intervention. ;

Related Conditions & MeSH terms

• Anhedonia
• Behavioral Symptoms
• Depression
• Depressive Disorder
• Disease
• Mental Disorder
• Mental Disorders
• Mood Disorders
• Mood Disturbance
• Psychotic Disorders
• Stress

• NCT number: NCT05223842
• Study type: Interventional
• Source: Vanderbilt University
• Status: Completed
• Phase: N/A
• Start date: December 1, 2021
• Completion date: January 20, 2023